Some studies found that the proportion of Breg cells and expression of IL-10 are significantly lower in patients with NMOSD compared to those with MS, suggesting that the degree of impairment to B cell regulatory function can be considered as a distinctive marker between NMOSD and MS (142). Here, IL10 is linked to myeloid sarcoma.